Form 4: Emergent BioSolutions EVP, Chief Financial Officer Richard S. Lindahl Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Richard S. Lindahl, EVP and Chief Financial Officer of Emergent BioSolutions Inc., reports a transaction involving the withholding of common stock to cover tax obligations.
Summary
- On June 8, 2024, Richard S. Lindahl, the EVP and Chief Financial Officer of Emergent BioSolutions Inc., had 2,733 shares of common stock withheld to cover tax obligations.
- The transaction was executed at a price of $6.19 per share.
- Following the transaction, Lindahl directly owns 156,009 shares of Emergent BioSolutions Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on a routine transaction related to tax obligations. It doesn't indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in the biopharmaceutical industry.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine tax withholding.
Key Dates
| Date | Description |
|---|---|
| 06/08/2024 | Date of transaction: shares of common stock withheld to pay taxes. |
| 06/11/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.